Company
Zynerba Pharmaceuticals, Inc. (0001621443)
Standardized SEC financial data for Zynerba Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001621443 · Pharmaceutical Preparations.
Return on equity
-75.8%
Free cash flow
-$23.2M
Current ratio
5.97×
EPS (diluted)
$-0.82
Ratios for fiscal year 2018, standardized from SEC filings.
Income statement
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $86K | — | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $62.5M | $59.8M | $70.1M | $59.2M | $67.8M | $50.6M |
| Total current assets |
Cash flow
| USD | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$25.8M | -$32.4M | -$34.8M | -$41.3M | -$33.5M | -$23.0M |
| Capital expenditures |
Get 0001621443 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001621443/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001621443/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"